Clinical Trials Browser

Phase 1/2 × Active not recruiting × Gastrointestinal Stromal Tumors × Clear all

NCT01991379 2025-12-04

MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

Phase 1/2 Active not recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors